Alumina Powder Containing δ, γ Crystal Phases: Evaluation of Osteoconductivity

Abstract:

Alumina powder containing δ , δ crystal phases (designated δAP) showed osteoconductivity. δAP was manufactured by fusing pulverized alumina powder and quenching it. The purpose of the present study was to evaluate osteoconductivity of δAP using rat tibiae. Alumina powder containing αcrystal phase (designated αAP) was used as a reference material. These two types of alumina powder were packed into the intramedullary canals of rat tibiae to evaluate osteoconductivity, as determined by an affinity index. Rats were sacrificed at 4 and 8 weeks after surgery. The affinity index, equal to the length of bone in direct contact with the powder surface expressed as a percentage of the total length of the powder surface, was calculated for each alumina powder at each interval. At 4 and 8 weeks, the affinity indices for δAP were significantly higher than those for αAP. For both δAP and αAP, there were no significant differences between the values for 4 and 8 weeks. This study revealed that the osteoconductivity of δAP was due to the alumina’s δcrystal phases. δAP shows promise as a basis for developing a osteoconductive biomaterial.

• Periodical: Key Engineering Materials (Volumes 309-311)
• Pages: 789-792
• DOI: https://doi.org/10.4028/www.scientific.net/KEM.309-311.789
• Online since: May 2006
• Authors: S. Shinzato, Takashi Nakamura, Koji Goto, Tadashi Kokubo
• Keywords: Aluminum (Al), Bioactive Bone Cement, Crystal Phase, Osteoconductivity

References

[1] Nakamura T, Kato H, Okada Y, Shinzato S, Kawanabe K, Tamura J, Kokubo T. Bioceramics Vol 13. Trans Tech Publications Ltd; 2000. pp.661-664.

[2] Shinzato S, Nakamura T, Kokubo T, Kitamura Y. Bioceramics Vol 13. Trans Tech Publications Ltd; 2000. pp.665-668.

[3] Shinzato S, Kobayashi M, Mousa WF, Kamimura M, Neo M, Kitamura Y, Kokubo T, Nakamura T: J Biomed Mater Res 2000; 51: 258-272.

DOI: 10.1002/(sici)1097-4636(200008)51:2<258::aid-jbm15>3.0.co;2-s

[4] Shinzato S, Nakamura T, Kokubo T, Kitamura Y: J Biomed Mater Res 2001; 54: 491-500.

[5] Shinzato S, Nakamura T, Kokubo T, Kitamura Y: J Biomed Mater Res 2001; 55: 277-284.

[6] Shinzato S, Nakamura T, Kokubo T, Kitamura Y: J Biomed Mater Res 2001; 56: 452-458.

[7] Shinzato S, Nakamura T, Tamura J, Kokubo T, Kitamura Y: J Biomed Mater Res 2001; 56: 571-577.

[8] Shinzato S, Nakamura T, Kokubo T, Kitamura Y: J Biomed Mater Res 2002; 59: 225-232.

[9] Shinzato S, Nakamura T, Ando K, Kokubo T, Kitamura Y: J Biomed Mater Res 2002; 60: 556-563.

[10] Kamimura M, Tamura J, Shinzato S, Kawanabe K, Neo M, Kokubo T, Nakamura T: J Biomed Mater Res 2002; 61: 564-571.

DOI: 10.1002/jbm.10214

[11] Shinzato S, Nakamura T, Kawanabe K, Kokubo T: J Biomed Mater Res 2003; 65B: 262-271.

DOI: 10.1002/jbm.b.10008

[12] Shinzato S, Nakamura T, Kawanabe K, Kokubo T: J Biomed Mater Res 2004. 2. 15; 68B: 132-139.

[13] Shinzato S, Nakamura T, Goto K, Kokubo T: Bioceramics Vol. 17 Trans Tech Publications Ltd. Switzerland 2005. pp.133-136.

[14] Nakamura T, Yamamuro Y, Higashi S, Kokubo T, Ito S: J Biomed Mater Res 1985; 19: 685-698.

[15] Kokubo T, Ito S, Shigematsu M, Sakka S, Yamamuro T: J Mater Sci 1985; 20: 2001-(2004).

[16] Shinzato S, Kobayashi M, Choju K, Kokubo T, Nakamura T: J Biomed Mater Res 1999; 46: 287-300.

DOI: 10.1002/(sici)1097-4636(199908)46:2<287::aid-jbm19>3.0.co;2-i

[17] Shinzato S, Nakamura T, Kokubo T, Kitamura Y: J Biomed Mater Res 2002; 60: 585-591.